Showing results (891-900 of 931) with videos related to

Sort By:
Pageof 94
The Lancet. Haematology|August 2, 2016
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trialGerald Illerhaus, Benjamin Kasenda, Gabriele Ihorst, et al.
Msystems|June 17, 2025
Bordetella pertussis exhibits genomic diversity within patients and laboratory cultureE Bouda, Y Peng, M M Williams, et al.
Open Forum Infectious Diseases|July 7, 2022
Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019Jeremy A W Gold, Andrew Revis, Stepy Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Association of Deep Learning-Derived Histologic Features of Placental Chorionic Villi with Maternal and Infant Characteristics in the New Hampshire Birth Cohort StudyElizabeth C Anderson, Gokul Srinivasan, Caitlin G Howe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 13, 2019
Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL)Gabriele Reinartz, Regina P Pyra, Georg Lenz, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 InflammasomeAngela Mackay, Juraj Velcicky, Nina Gommermann, et al.
Frontiers in Immunology|October 24, 2022
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19Sixten Körper, Eva Vanessa Schrezenmeier, Hector Rincon-Arevalo, et al.
British Journal of Haematology|September 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trialHermann Einsele, Monika Engelhardt, Christoph Tapprich, et al.
Annals of Hematology|October 4, 2016
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 studyRichard F Schlenk, Michael Lübbert, Axel Benner, et al.
The Journal of Clinical Investigation|August 31, 2021
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19Sixten Körper, Manfred Weiss, Daniel Zickler, et al.
Pageof 94